KRYSTAL WEAVER: Open Payments
NPI 1992152144 · MORRISTOWN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$847 in 54 payments from 16 companies in 2025. Trend: 2023 $1,106 · 2024 $1,091 · 2025 $847
Food & beverage: $847
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $143 |
| Amgen Inc. | 17 | $142 |
| Axsome Therapeutics, Inc. | 4 | $94 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $77 |
| Verona Pharma, Inc. | 3 | $71 |
| Vanda Pharmaceuticals Inc. | 3 | $62 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $40 |
| Corcept Therapeutics | 2 | $40 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $29 |
Products named: OTEZLA, CAPLYTA, Ohtuvayre, Ozempic, Sunosi, Auvelity, Wegovy, XIFAXAN.
Industry payments across TN — which companies pay providers there.
